RN7SL430P

Across TCGA pan-cancer cohorts, RN7SL430P RNA is linked to patient survival in 11 of 34 cancer types, making it the most broadly survival-associated RN7SL430P data layer.

The strongest signal is observed in head and neck squamous cell carcinoma (HNSC), where higher RN7SL430P RNA is associated with better overall survival. In most high-consensus cancer types, elevated RN7SL430P expression acts as an unfavorable survival marker, although some lineages such as HNSC and STAD show a favorable association.

HNSC, KICH, and SKCM are the cancer types where RN7SL430P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
HNSC	OS	Tertile	All	0.609	0.327	<.001	129	view →
KICH	OS	Tertile	All	0.852	0.979	.002	45	view →
SKCM	DFS	Tertile	II,III,IV	0.443	0.740	<.001	36	view →
ACC	DFS	Tertile	IV	0.010	0.383	<.001	36	view →
READ	DFS	Tertile	III,IV	0.433	0.782	.006	36	view →
LGG	OS	Tertile	All	0.197	0.454	<.001	36	view →
STAD	OS	Tertile	IV	0.670	0.164	.005	15	view →
GBM	OS	Tertile	All	0.239	0.425	.034	9	view →
MESO	DFS	Tertile	IV	0.130	0.405	.019	9	view →
ESCA	OS	Tertile	II,III,IV	0.464	1.000	.031	6	view →
PCPG	DFS	Tertile	All	0.523	0.840	.015	6	view →

Pink = unfavorable, green = favorable. Showing the 11 strongest of 11 lineages.

RN7SL430P–HNSC (OS)

Open the HNSC breakdown →